tiprankstipranks
Advertisement
Advertisement

MGTX Stock Latest News

Acting FDA head vows to block political interference, Endpoint News says
The FlyActing FDA head vows to block political interference, Endpoint News says
14h ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
PremiumThe Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
3d ago
AZN
BMY
MeiraGTx: Buy Rating Reiterated as Pivotal AQUAx2 Path and Dual Launch Opportunities Support Unchanged $20 Price Target
PremiumRatings
MeiraGTx: Buy Rating Reiterated as Pivotal AQUAx2 Path and Dual Launch Opportunities Support Unchanged $20 Price Target
10d ago
MGTX
MeiraGTx reports Q1 EPS (57c), consensus (45c)
PremiumThe Fly
MeiraGTx reports Q1 EPS (57c), consensus (45c)
22d ago
MGTX
FDA Commissioner Marty Makary resigns
PremiumThe Fly
FDA Commissioner Marty Makary resigns
24d ago
AZN
BMY
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe FlyTrump Trade: Trump to suspend tariff-rate quotas on beef imports
24d ago
AZN
BMY
Trump Trade: U.S. plans AI security order without required model tests
Premium
The Fly
Trump Trade: U.S. plans AI security order without required model tests
25d ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
Premium
The Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
25d ago
DYN
RNA
MeiraGTx Forms Strategic Gene Therapy Collaboration with Hologen
PremiumCompany Announcements
MeiraGTx Forms Strategic Gene Therapy Collaboration with Hologen
1M ago
8K
MGTX
MeiraGTx price target raised to $30 from $26 at Piper Sandler
PremiumThe Fly
MeiraGTx price target raised to $30 from $26 at Piper Sandler
1M ago
JNJ
MGTX
MeiraGTx price target raised to $24 from $16 at RBC Capital
PremiumThe Fly
MeiraGTx price target raised to $24 from $16 at RBC Capital
2M ago
MGTX
MeiraGTx Announces Public Equity Offering to Fund Growth
PremiumCompany Announcements
MeiraGTx Announces Public Equity Offering to Fund Growth
2M ago
8K
MGTX
MeiraGTx announces three-year data from Phase 1 AQUAx study
PremiumThe FlyMeiraGTx announces three-year data from Phase 1 AQUAx study
2M ago
MGTX
MeiraGTx announces acquisition of bota-vec for treatment of XLRP
Premium
The Fly
MeiraGTx announces acquisition of bota-vec for treatment of XLRP
2M ago
JNJ
MGTX
MeiraGTx Reacquires Bota-Vec Rights, Advances XLRP Program
Premium
Company Announcements
MeiraGTx Reacquires Bota-Vec Rights, Advances XLRP Program
2M ago
8K
MGTX
MeiraGTx Reports Durable Phase 1 AQUAx Gene Therapy Data
PremiumCompany Announcements
MeiraGTx Reports Durable Phase 1 AQUAx Gene Therapy Data
2M ago
8K
MGTX
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
PremiumThe Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
2M ago
DYN
RNA
MeiraGTx price target lowered to $18 from $20 at Evercore ISI
PremiumThe Fly
MeiraGTx price target lowered to $18 from $20 at Evercore ISI
2M ago
MGTX
MeiraGTx’s AI Push Raises Operational, Regulatory and Data Privacy Risk Concerns
PremiumCompany Announcements
MeiraGTx’s AI Push Raises Operational, Regulatory and Data Privacy Risk Concerns
2M ago
MGTX
MeiraGTx price target lowered to $26 from $30 at Piper Sandler
PremiumThe FlyMeiraGTx price target lowered to $26 from $30 at Piper Sandler
2M ago
MGTX
MeiraGTx price target raised to $16 from $14 at BofA
Premium
The Fly
MeiraGTx price target raised to $16 from $14 at BofA
2M ago
MGTX
MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances
Premium
Company Announcements
MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances
2M ago
8K
MGTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >